Title: Pellerito's Corner - January 2015
Author: Peter Pellerito, President & CEO
Facility: ImaCor Inc. Garden City, NY

Welcome to our January newsletter. Our focus is on avoiding fluid overload in critically ill patients, a problem that advanced hemodynamic management addresses specifically. With less than 50% of hemodynamically unstable patients in the intensive care unit and operating room responding to fluid challenge, accurate assessment of cardiac preload and contractility become crucial in resuscitating patients.1 By providing direct, fast, and accurate visualization of the heart, the hTEE program helps prevent fluid overload through guided resuscitation.

Recent research from St. George's Healthcare (London, UK) and Charité – Universitätsmedizin (Berlin, Germany) and has found advanced hemodynamic management with hTEE to be advantageous in managing therapy and identifying RV failure. Nick Fletcher, MBBS, and his team at St. George's Healthcare found that hTEE resulted in a change in therapy in 90.2% of patients which led to an improvement in the hemodynamic status of 80.5% of patients. hTEE also identified RV failure in 67.6% of these patients, and had a direct therapeutic impact in 68%. Sascha Treskatsch, PhD, MD, of Charité and his team reported that hTEE has gained clinical relevance in guiding goal-directed hemodynamic therapy, such as with volume replacement or cardiovascular agents. The findings are published in the Journal of Cardiothoracic and Vascular Anesthesia and AINS (Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie) respectively.

A primary focus at ImaCor is to translate these important papers into clinical action for all of our customers. We provide ongoing education that shares best practices in how advanced hemodynamic management programs help improve quality. The research by our users will continue to provide us with evidence on the benefits to patients; we also work to engage C-level executives with how this enhances cost containment.

Improving quality improves outcomes and reduces costs. Simply, it saves lives and it saves money. To learn more, please contact me at This email address is being protected from spambots. You need JavaScript enabled to view it. or visit us at www.imacorinc.com.

With kind regards,


Peter Pellerito



1. Marik, Paul E. "Hemodynamic parameters to guide fluid therapy." Transfusion Alternatives in Transfusion Medicine 11.3 (2010): 102-112.